Go back

Japan-based health fund invests in neglected diseases

       

Projects will target Leishmaniasis, Buruli ulcer and Chagas disease

The Japan-based Global Health Innovative Technology Fund announced on 18 May that it will invest about 960 million Yen (US$8.8m) in four new projects to develop treatments and diagnostics for neglected diseases.

Two projects will aim to develop diagnostics for Buruli ulcer and congenital Chagas disease. The first will be led by a partnership between Japanese and Spanish scientists, the second by a partnership involving Japanese and Swiss scientists.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.